Oppenheimer Maintains Outperform on Guardian Pharmacy Service, Raises Price Target to $43
Benzinga Newsdesk 5 months ago
NewsPrice TargetAnalyst Ratings
Oppenheimer analyst Michael Wiederhorn maintains Guardian Pharmacy Service (NYSE:GRDN) with a Outperform and raises the price target from $38 to $43.
Oppenheimer analyst Michael Wiederhorn maintains Guardian Pharmacy Service (NYSE:GRDN) with a Outperform and raises the price target from $38 to $43.